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Introduction:  Contrast-enhanced  multidetector  computed  tomography  (MDCT)  is  useful  for  the
diagnosis  of  pulmonary  embolism  (PE).  However,  current  guidelines  do  not  support  its  use  for
risk assessment  in  acute  PE  patients.
Objectives:  We  compared  the  prognostic  impact  of  MDCT-derived  indices  regarding  medium-
term mortality  in  a  population  of  intermediate-  to  high-risk  PE  patients,  mostly  treated  by
thrombolysis.
Methods: Thirty-nine  consecutive  patients  admitted  to  an  intensive  care  unit  with  acute  PE
were studied.  All  patients  had  a  pulmonary  MDCT  on  admission  to  the  emergency  room  as  part  of
the diagnostic  algorithm.  We  assessed  the  following  MDCT  variables:  right  ventricular/left  ven-
tricular diameter  (RV/LV)  ratio,  arterial  obstruction  index,  pulmonary  artery-to-aorta  diameter
ratio and  azygos  vein  diameter.  A  33-month  follow-up  was  performed.
Results:  Mean  age  was  59.1±19.6  years,  with  80%  of  patients  receiving  thrombolysis.  Follow-
up all-cause  mortality  was  12.8%.  Of  the  MDCT-derived  variables,  only  the  RV/LV  ratio  had
signiﬁcant  predictive  value,  being  higher  in  patients  who  suffered  the  endpoint  (1.6±0.5  vs.
1.9±0.4, p=0.046).  Patients  with  an  RV/LV  ratio  ≥1.8  had  11-fold  higher  medium-term  all-
cause mortality  (3.8%  vs.  38.8%,  p<0.001).  Regarding  this  endpoint,  the  c-statistic  was  0.78
loaded from http://http://www.elsevier.pt, day 19/02/2013. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.(95% CI,  0.60--0.96)  for  RV/LV  ratio  and  calibration  was  good  (goodness-of-ﬁt  p=0.594).  No
other radiological  index  was  predictive  of  mortality.
Conclusions: MDCT  gives  the  possibility,  in  a  single  imaging  procedure,  of  diagnos-
ing and  assessing  the  prognosis  of  patients  with  intermediate-  to  high-risk  PE.
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Although  further  studies  are  needed,  the  simple-to-calculate  RV/LV  ratio  has  good  discrimina-
tion and  calibration  for  predicting  poorer  outcomes  in  patients  with  acute  PE.












Angiograﬁa  pulmonar  por  tomograﬁa  computadorizada  em  doentes  com
tromboembolia  pumonar  de  médio  a  alto  risco:  avaliac¸ão  diagnóstica  e  prognóstica
num  só  exame
Resumo
Introduc¸ão:  A  angiograﬁa  pulmonar  por  tomograﬁa  computadorizada  com  contraste  (angio-TC)
é recomendada  para  o  diagnóstico  mas  não  para  a  estratiﬁcac¸ão  de  risco  em  doentes  com
tromboembolia  pulmonar  (TEP).
Objectivos:  Determinar  o  impacto  prognóstico  a  médio-prazo  de  vários  índices  radiológicos
obtidos  na  angio-TC  em  doentes  com  TEP  de  médio  a  alto  risco,  a  maioria  tratados  com
ﬁbrinólise.
Métodos: Estudaram-se  39  doentes  admitidos  numa  unidade  de  cuidados  intensivos  por  TEP,
todos com  angio-TC  prévia  realizada  na  urgência  e  seguiram-se  durante  33  meses.  Mediram-se
as seguintes  variáveis:  razão  entre  os  diâmetros  do  ventrículo  direito  e  ventrículo  esquerdo
(índice  VD/VE),  índice  de  obstruc¸ão  arterial,  razão  ente  os  diâmetros  da  artéria  pulmonar  e
aorta e  diâmetro  da  veia  ázigos.
Resultados:  A  idade  média  foi  de  59,1  ±  19,6  anos;  80%  dos  doentes  foram  tratados  com
ﬁbrinólise.  Durante  o  período  de  seguimento  clínico,  a  mortalidade  foi  12,8%.  Das  variáveis
analisadas,  apenas  o  índice  VD/VE  demonstrou  valor  preditivo,  sendo  signiﬁcativamente  mais
elevado nos  doentes  que  faleceram  (1,6  ±  0,5  versus  1,9  ±  0,4,  p=0,046).  Os  doentes  com  um
índice VD/VE  ≥  1,8  tiveram  uma  incidência  11  vezes  superior  de  mortalidade  a  médio  prazo
(3,8% versus  38,8%,  p  <  0,001).  Relativamente  a  este  endpoint,  o  c-statistic  foi  de  0,78  (95%  IC
0,60--0,96) e  a  calibrac¸ão  elevada  (goodness-of-ﬁt  p=0,594).  Nenhum  outro  índice  radiológico
demonstrou  associac¸ão  com  a  mortalidade.
Conclusões: A angio-TC  permite  num  único  exame,  em  doentes  de  médio  e  alto  risco,  diagnos-
ticar e  estratiﬁcar  o  risco  da  TEP.  Apesar  de  serem  necessários  mais  estudos,  o  índice  VD/VE
pode identiﬁcar  doentes  com  pior  prognóstico  após  uma  TEP.
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ulmonary  embolism  (PE)  ranges  from  asymptomatic  forms
o  life-threatening  massive  arterial  pulmonary  bed  obstruc-
ion  and  may  be  responsible  for  up  to  15%  of  all  in-hospital
eaths.1 Mortality  is  thought  to  be  caused  in  part  by  right
entricular  (RV)  pressure  overload  resulting  in  RV  dilatation
nd  dysfunction  (RVD),  ischemia  with  ensuing  failure  and
ltimately  death.2
PE  can  be  difﬁcult  to  diagnose  and  risk  stratiﬁcation  is
aramount,  in  order  to  choose  the  best  therapeutic  option
or  each  patient.3,4 Contrast-enhanced  multidetector  com-
uted  tomography  (MDCT)  is  currently  the  gold  standard
or  diagnosing  PE  and  has  a  growing  role  in  risk  stratiﬁca-
ion.  Recent  evidence  has  conﬁrmed  the  good  correlation
etween  echocardiography  and  MDCT-derived  indices  of  RVD
nd  the  ratio  of  right  ventricular  to  left  ventricular  (RV/LV)
hort-axis  diameters  has  emerged  as  the  most  accurate  sign
f  RVD.5,6 Also,  the  extent  of  PE  (the  thrombus  burden  in  the
ulmonary  bed)  has  been  proposed  as  an  important  param-
ter  for  predicting  RVD  and  death.7--9 At  the  same  time,  the




The  lower  threshold  of  clinical  suspicion  and  greater  avail-
bility  of  diagnostic  techniques.10
However,  the  majority  of  studies  assessing  RV/LV  ratios
xclude  the  most  severe  patients  from  MDCT  analysis,
articularly  hemodynamically  unstable  patients.  This  is
eﬂected  by  the  low  mean  RV/LV  ratios  reported  in
he  literature,  ranging  from  1.15,11 to  1.32.12,13 Moreover,
he  proportion  of  patients  undergoing  thrombolytic  therapy
n  these  studies  was  also  low.
Our  aim  was  to  compare  the  prognostic  impact  of  various
DCT-derived  RVD  indices  on  medium-term  mortality  in  a
opulation  of  intermediate-  to  high-risk  PE  patients,  most
f  them  treated  by  thrombolysis.
ethods
atient  populatione  retrospectively  studied  all  patients  with  intermediate-
o  high-risk  PE  admitted  to  the  intensive  care  unit  of
ur  department  between  November  2005  and  July  2008.
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MDCT  in  all  patients.  The  clinical  severity  of  pulmonary
embolism  was  stratiﬁed  using  the  system  proposed  by  the
ESC  guidelines.3 All  patients  had  intermediate-  (positive
troponin  I  and/or  RV  dilatation/dysfunction  on  echocar-
diogram)  or  high-risk  PE  (shock,  deﬁned  by  systolic  blood
pressure  <90  mmHg).  Medical  records  of  patients  who  were
eligible  for  the  study  were  reviewed  by  two  of  the  authors,
who  were  not  involved  in  MDCT  reporting.  Clinical  data
was  collected  prospectively,  including  demographic,  clin-
ical,  laboratory  and  echocardiographic  data.  We  assessed
a  medium-term  endpoint  of  all-cause  mortality,  and  in-
hospital  clinical  deterioration  -- a  composite  of  in-hospital
death,  need  for  mechanical  ventilation,  inotrope  usage
and  rethrombolysis  -- was  also  assessed.  The  protocol  was
reviewed  by  the  institutional  board.  The  population  was
divided  into  two  groups,  classiﬁed  by  survival  status  at
follow-up  (alive  or  deceased).
Therapeutic  protocol
Decisions  on  treatment  were  the  responsibility  of  the
attending  physician.  The  indications  for  thrombolytic  ther-
apy  were  hypotension,  severe  hypoxemia,  evidence  of  RV
dysfunction  on  transthoracic  echocardiography  and  evi-
dence  of  severe  pulmonary  thrombus  burden.  Thirty-three
(84.6%)  patients  underwent  thrombolysis  with  alteplase
(Actilyse®,  Boehringer  Ingelheim  Pharma,  Germany)  fol-
lowed  by  a  continuous  intravenous  infusion  of  heparin.  No
patient  underwent  surgical  or  catheter-based  embolectomy.
Mean  follow-up  was  three  years  and  survival  status  was  avail-
able  for  97.4%  of  patients.
Transthoracic  echocardiography
Bedside  standard  two-dimensional  echocardiography  was
performed  by  the  on-call  cardiologist  with  a  portable  Aloka®
echocardiograph  and  was  available  in  30  patients  (77%).  Pul-
monary  artery  systolic  pressure  (PASP)  was  derived  from  the
right  atrioventricular  pressure  gradient  using  peak  velocity
of  tricuspid  regurgitation  with  continuous  wave  Doppler  in
apical  four-chamber  view  and  the  modiﬁed  Bernoulli  equa-
tion.  Right  atrial  pressure  was  considered  equal  to  5  mmHg
or  10  mmHg  according  to  whether  or  not  the  inferior  vena
cava  collapsed  during  inspiration,  respectively.
Contrast-enhanced  multidetector  computed
tomography
All  MDCT  examinations  were  performed  during  patient  stay
in  the  emergency  department  by  the  on-call  radiologist.
Images  were  obtained  on  either  a  4-slice  or  a  64-slice  multi-
detector  CT  scanner  during  inspiratory  breath  holding  when
possible  or  during  quiet  breathing  if  the  patient  was  short  of
breath.  For  patients  on  mechanical  ventilation,  ventilation
was  manually  suspended  in  deep  inspiration.  Intravenous
injection  of  contrast  medium  (80  ml  of  iodinated  contrast
material  with  a  concentration  of  400  mg/ml,  at  a  rate  of
3.5--5  ml/s)  was  started  using  a  bolus  tracking  device,  when





00  Hounsﬁeld  units  (HU)  for  the  4-slice  MDCT  and  180  HU
or  the  64-slice  MDCT  scanners,  respectively.
Caudocranial  helical  acquisition  was  obtained  with  a
ollimation  of  0.625--1.25  mm  and  a  pitch  of  0.9--1.5.
cquisition  time  was  0.5  s per  rotation  and  tube  cur-
ent  was  modulated  between  100  and  700  mA  and  100
nd  140  kV.  The  z-axis  coverage  started  2  cm  below  the
iaphragm  and  extended  up  to  the  upper  part  of  the  aor-
ic  arch,  enabling  visualization  of  the  heart  and  pulmonary
rteries  up  to  the  subsegmental  level.  Images  were  imme-
iately  analyzed  by  the  on-call  radiologist,  who  diagnosed
E  based  on  the  presence  of  pulmonary  arterial  ﬁlling
efects.
fﬂine  image  analysis
ll  MDCT  scans  were  retrospectively  reviewed  by  two  inde-
endent  radiologists  (with  4  and  13  years  of  experience,
espectively)  who  were  blinded  to  clinical  data,  results
f  echocardiography  and  outcomes.  The  readers  scored
ulmonary  arterial  thrombus  load  using  the  system  pro-
osed  by  Mastora  et  al.7 The  widths  of  the  ventricular
hambers  were  evaluated  based  on  a  single  axial  image
btained  at  the  plane  of  maximal  visualization  of  the
entricular  chambers,  which  was  typically  at  the  level
f  the  mitral  valve.  Axes  were  measured  in  diastole  on
 single  transverse  scan  perpendicular  to  the  long  axis
f  the  heart  and  were  deﬁned  as  the  largest  distance
etween  the  inner  aspect  of  the  interventricular  septum
nd  the  ventricular  free  wall.14 The  right  ventricle  was
onsidered  dilated  if  the  right  ventricular  chamber  was
ider  than  the  left  ventricular  chamber  along  the  short
xis.
Vascular  measurements  for  the  diameters  of  the  pul-
onary  artery,  aorta  and  azygos  vein  were  also  obtained
sed  adjusted  multiplanar  images  in  the  plane  perpendicu-
ar  to  the  long  axis  of  the  vessel  being  considered  and  were
cquired  using  electronic  calipers.  The  pulmonary  artery
as  measured  near  its  branching,  the  aorta  at  the  middle
hird  of  its  ascending  portion  and  the  azygos  vein  where  it
aced  the  right  tracheal  wall.
tatistical  analysis
ll  variables  were  tested  for  normality  using  the
olmogorov-Smirnov  test.  If  normal,  values  are  presented
s  mean  values  ±  standard  deviation.  If  the  distribution
as  skewed,  values  are  presented  as  medians,  ﬁrst  and
hird  quartiles.  Correlations  were  analyzed  with  the  Pear-
on  correlation.  Results  are  presented  as  coefﬁcients  of
orrelation  (r).  The  area  under  the  receiver  operating
haracteristic  curve  (AUROC)  was  used  for  discrimination;
his  provides  a  measure  of  overall  accuracy  that  is  inde-
endent  of  the  decision  criterion.  The  criterion  value  with
he  highest  accuracy  is  the  value  with  the  minimum  false
egative  and  false  positive  results  at  the  same  time.  Sta-
istical  analyses  were  performed  using  SPSS  13.0® software
Chicago,  Illinois).  AUROC  analysis  was  performed  using
edCalc® software  version  6.12  (MedCalc,  Mariakerke,
elgium).
10  R.  Baptista  et  al.
Table  1  Clinical  characteristics  and  laboratory  variables  at  initial  diagnosis.
Total  (n=39) Survivors(n=34)  Deceased(n=5)  p
Age,  years  59.1  ±  19.6  56.0  ±  19.0  80.3  ±  3.9  0.001
Body mass  index,  kg/m2 29.2  ±  4.2  29.1  ±  4.3  29.8  ±  4  NS
Mean arterial  pressure,  mmHg  90.5  ±  13.4  91.9  ±  13.4  81.5  ±  9.9  NS
Heart rate,  bpm  97  ±  19.3  97.6  ±  18.8  92.4  ±  24.4  NS
O2 partial  pressure,  mmHg  63.8  ±  18.8  64.7  ±  20  58.4  ±  6.9  NS
CO2 partial  pressure,  mmHg  32.6  ±  5.7  32.8  ±  5.9  30.9  ±  4.9  NS
D-dimers, g/l  7.9  ±  6.1  6.8  ±  5.2  16.3  ±  6.8  0.02
Blood glucose,  mg/dl 158.9  ±  66.6  159.1  ±  67.6  157.8  ±  67.1  NS
Troponin I,  ng/ml 0.2±  0.3  0.2±  0.3  0.1±  0.1  NS
eGFR, ml/min/m2 71.9±  22.9  74.3±  22.3  55.7±  22.7  NS
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linical  data
 total  of  39  consecutive  patients  admitted  to  our  intensive
are  unit  with  an  MDCT-conﬁrmed  diagnosis  of  PE  were
tudied.  All  MDCT  parameters  were  assessable  in  all
atients.  Baseline  characteristics  are  presented  in  Table  1.
ean  age  was  59.1±19.6  years  (range  22--85  years),  with
 majority  of  females  (53.8%).  Body  mass  index  was  high,
ith  a  mean  value  of  29.2±4.2  kg/m2.  No  differences  were
ound  in  mean  blood  pressure  or  heart  rate  between  the
roups;  similarly,  no  differences  were  found  between  groups
egarding  arterial  blood  gases,  blood  glucose,  troponin  I,
stimated  glomerular  ﬁltration  rate  or  C-reactive  protein  on
dmission.  D-dimers  were  higher  in  patients  who  died  than
n  surviving  patients  (16.3±6.8  vs.  6.8±5.2  g/l,  p=0.02).
Clinical  data  are  presented  in  Table  2.  Most  patients  pre-
ented  with  dyspnea  (69.2%),  followed  by  chest  pain  (51.3%).





Table  2  Symptoms,  risk  factors  and  diagnostic  test  data  at  diagn
Total
(n=39)
Symptoms,  n  (%)
Dyspnea  27  (69.2)  
Chest pain  20  (51.3)  
Cough 4  (10.3)  
Syncope 12  (30.8)  
Risk factors,  n  (%)
Recent  major  surgery  8  (20.5)  
Neoplasia 7  (17.9)  
Prior pulmonary  embolism/DVT  7  (17.9)  
Diagnostic tests,  n  (%)
Electrocardiogram
S1Q3T3 pattern  9  (23.1)  
Inverted T  waves  in  V1--V3  11  (28.2)  
Echocardiogram
PASP, mmHg  56.6  ±  17.0  
DVT: deep vein thrombosis; PASP: pulmonary artery systolic pressure.the Modiﬁcation in Diet in Renal Disease equation.
ommon  risk  factor  for  PE  was  recent  major  surgery  (20.5%),
losely  followed  by  neoplasia  (17.9%)  and  a  prior  throm-
oembolic  event  (17.9%).  A  typical  S1Q3T3 pattern  on  the
urface  ECG  was  found  in  23.1%  of  patients  and  in  28.2%  right
entricular  strain  was  present.  The  bedside  echocardiogram
ocumented  mean  PASP  of  56.6±17.0  mmHg,  with  no  sig-
iﬁcant  differences  between  groups.  Regarding  treatment,
ore  than  80%  of  patients  underwent  thrombolysis  (82.4
s.  100%,  p=0.307).  Five  percent  of  these  were  high-risk
atients  according  to  the  ESC  guidelines,  with  hemodynamic
nstability,  while  95%  were  in  the  intermediate-risk  stratum.
utcomes
here  were  ﬁve  deaths,  three  of  them  in-hospital  (7.7%).
one  was  due  to  bleeding  complications.  Median  time  to
eath  was  six  days  (range  1--40  days).  The  in-hospital  com-
ined  endpoint  of  clinical  deterioration  occurred  in  10.3%
f  patients.  During  the  three-year  medium-term  follow-up,







24  (70.6)  3  (60.0)  NS
19  (55.9)  1  (20.0)  NS
4  (11.8)  0  (0.0)  --
9  (26.5)  3  (60.0)  NS
7  (20.6)  1  (20.0)  NS
7  (20.6)  1  (17.9)  NS
1  (20.6)  0  (0.0)  --
8  (23.5)  1  (20.0)  NS
9  (26.5)  2  (40.0)  NS
55.7  ±  15.1  64.0  ±  36.8  NS
Multidetector  computed  tomography  in  pulmonary  embolism  11








Arterial  obstruction  index  49.4±16.9  49.2±17.9  51.1±8.6  NS
Obstruction  ≥40%,  n  (%)  28  (71.8)  23  (67.6)  5  (100.0)  NS
RV diameter,  cm  5.3±0.8  5.3±0.8  5.3±0.5  NS
LV diameter,  cm  3.5±0.9  3.6±0.9  3.1±0.7  NS
RV/LV ratio  1.7±0.5  1.6±0.5  2.0±0.4  0.046
PA diameter,  cm 3.1±0.4  3.1±0.4  3.2±0.3  NS
Aortic diameter,  cm 3.3±0.5 3.3±0.5  3.5±0.1  NS
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Quantitative  measurements
Results  of  the  MDCT  variables  are  shown  in  Table  3.  Reﬂect-
ing  the  overall  severity  of  the  population,  the  arterial
obstruction  index  was  over  40%  in  71.8%  of  patients,  with
a  mean  of  49.4±16.9%.  Although  this  index  correlated  sig-
niﬁcantly  with  age,  heart  rate,  troponin  I and  RV/LV  ratio
(Table  4),  it  was  not  predictive  of  medium-term  mortality.
This  high  arterial  obstruction  index  was  accompanied  by  a
very  high  mean  RV/LV  ratio  of  1.7±0.5.  This  variable  dif-
fered  signiﬁcantly  between  the  groups,  with  higher  values
in  patients  who  died  during  follow-up  (2.0±0.4  vs.  1.6±0.5,
p=0.046).  None  of  the  other  radiological  variables  correlated
signiﬁcantly  with  mortality.  Patients  who  underwent  throm-
bolysis  had  similar  RV/LV  ratios  to  patients  not  receiving
thrombolysis  (1.6±0.7  vs.  1.7±0.5,  p=0.407).
On  AUROC  analysis,  the  best  RV/LV  ratio  cut-off  to  predict
medium-term  mortality  in  this  intermediate-  to  high-risk  PE
population  was  1.81,  with  a  c-statistic  of  0.78  (95%  conﬁ-
dence  interval  [CI],  0.60--0.96).  Patients  with  an  RV/LV  ratio
of  more  than  1.8  had  11-fold  higher  mortality  than  patients
with  RV/LV  ratio  <1.8  (3.8%  vs.  38.8%,  p<0.001).  This  com-
pares  with  an  established  risk  marker  in  PE,  troponin  I,
which,  in  our  population,  yielded  a  c-statistic  of  0.66  (95%
CI,  0.34--0.97)  for  medium-term  mortality.
Sensitivity  and  speciﬁcity  (95%  CI)  of  RV  enlargement
on  MDCT  for  predicting  death  during  follow-up  were  80.0%
and  76.5%,  respectively.  Negative  and  positive  predictive
values  of  RV  enlargement  on  MDCT  for  medium-term
all-cause  mortality  were  96.3%  (95%  CI,  81.0--99.9%)
and  33.3%  (95%  CI,  9.9--65.1%),  respectively.  The  RV/LV






Table  4  Correlations  of  clinical,  laboratory  and  echocardiograph
Arterial  obstruction  index  
Pearson  coefﬁcient
Age,  years 0.373  
Heart rate,  bpm  0.432  
Troponin I,  ng/ml  0.446  
PASP, mmHg  0.318  
bpm: beats per minute; PASP: pulmonary artery systolic pressure.1.1±0.3 0.9±0.2 NS
iscussion
he  results  of  our  study  suggest  than  in  this  severely  ill,
ntermediate-  to  high-risk  PE  population,  only  RV/LV  ratio
ad  the  ability  to  predict  medium-term  mortality.  Other
adiological  parameters,  including  azygos  vein  diameter,
ortic  diameter,  pulmonary  artery  diameter  and  arterial
bstruction  index,  showed  no  correlation  with  the  end-
oint  of  interest.  Analysis  of  the  data  on  survivors  and
on-survivors  clearly  demonstrated  a  signiﬁcant  difference
n  mean  RV/LV  ratios  between  these  groups.
Follow-up  all-cause  mortality  was  12.8%,  similar  to  the
ate  seen  in  larger  studies,  suggesting  that  our  sample
s  a  representative  cohort  of  PE  patients.  However,  most
tudies  report  short-term  (usually  30--90-day)  mortality,11,13
hereas  we  report  three-year  follow-up  data.
Although  echocardiography  has  long  been  recognized  as
 rapid,  non-invasive  and  sensitive  method  for  demonstrat-
ng  RVD  in  acute  PE  patients,  it  is  not  routinely  performed
ue  to  its  limited  availability  in  emergency  rooms  and  poor
mage  quality  in  some  patients.  As  MDCT  has  become  the
avored  diagnostic  method  in  acute  PE,  its  emergence  as
 diagnostic  tool  that  can  simultaneously  risk-stratify  the
atient  is  of  great  value.  Arterial  obstruction  index  and
V/LV  ratio  are  the  most  extensively  studied  prognostic
ariables  in  patients  with  PE.  The  current  literature  is  not
lear  regarding  the  association  of  radiological  indices  of  PE
everity  and  morbidity  and  mortality,  especially  in  predict-
ng  long-term  outcomes.  Moreover,  most  studies  only  include
atients  with  less  severe  forms  of  PE,  a  fact  that  is  high-
ighted  by  the  low  arterial  obstruction  and  RV/LV  indices
eported.5,11,12 Two  studies  focused  only  on  MDCT  ﬁndings  in
assive  PE,  using  different  deﬁnitions.  Ocak  et  al.  studied
ic  data  with  MDCT  parameters.
RV/LV  ratio
p  Pearson  coefﬁcient  p
0.019  0.353  0.027
0.006  0.366  0.022
0.012  0.315  0.085
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hree  patients  with  massive  PE  and  concluded  that  reduced
eft  atrial  and  pulmonary  vein  diameters  were  important
ndings  on  MDCT.15 Lim  et  al.  reported  data  on  14  patients
ith  acute  massive  PE,  concluding  that  MDCT  identiﬁed
atients  with  right  ventricular  dysfunction  with  high  sen-
itivity  and  speciﬁcity,  a  ﬁnding  of  relevance  in  hospitals
ithout  echocardiography  available  around  the  clock.7
One  question  that  arises  is  why  arterial  obstruction  index
or  PA  thrombus  load)  was  not  associated  with  mortality.
lthough  correlated  with  troponin  increase  and  RV/LV  ratio
n  this  intermediate-  to  high-risk  population,  it  did  not
redict  RV  failure  or  death.  Our  results  are  in  agreement
ith  those  of  Collomb  et  al.16 and  Ghaye  et  al.,14 suppor-
ing  the  idea  that  the  most  important  prognostic  factor  is
ow  the  RV  responds  to  the  sudden  increase  in  pulmonary
ascular  resistance  and  not  the  extent  of  the  thrombus  bur-
en  in  the  pulmonary  bed.  Several  authors  suggest  that  it  is
ncoupling  of  RV  resources  from  the  pulmonary  arterial  load,
ather  than  obstruction,  that  causes  RV  failure.17,18 This  is
urther  evidence  that  ﬁxed  variables,  such  as  obstruction
ndex  and  pulmonary  systolic  pressure,  are  unable  to  predict
orbidity,  as  they  do  not  reﬂect  RV-PA  coupling.  Added  to
he  fact  that  calculation  of  the  arterial  obstruction  index  is
ifﬁcult  and  time-consuming,  the  effectiveness  of  this  index
n  the  acute  setting  remains  to  be  proven.
The  RV/LV  ratio,  in  contrast,  reﬂects  RV  volume  and
ressure  overload  and  thus  reﬂects  the  pathophysiological
rocesses  leading  to  heart  failure  and  death.  Leftward  shif-
ing  of  the  interventricular  septum  leads  to  impairment
f  left  ventricular  distensibility  and  pericardial  constraint,
imiting  left  ventricular  ﬁlling  and  cardiac  output.  At
he  same  time,  acute  RV  dilatation  aggravates  tricuspid
egurgitation,  itself  worsening  RV  performance.  Several
eports5,6,14,19,20 and  a  meta-analysis13 suggest  that  an  RV/LV
atio  >1.0  (or  0.9  in  reconstructed  four-chamber  views)  is  a
trong  prognostic  marker  in  patients  with  acute  PE.  Although
here  is  some  evidence  that  reconstructed  four-chamber
iews  may  be  superior  to  axial  views  for  the  identiﬁcation
f  high-risk  patients,19 several  studies  have  found  robust
rognostic  value  using  standard  axial  acquisitions  to  calcu-
ate  the  RV/LV  ratio.11,12,20
In  a  large  retrospective  series  of  431  patients,  30-day
ortality  was  15.6%  in  patients  with  RV  enlargement  (recon-
tructed  four-chamber  views),  deﬁned  as  RV/LV  ratio  >0.9
n  MDCT,  compared  to  7.7%  in  those  without  this  ﬁnding.6
n  the  above-mentioned  meta-analysis  of  two  studies  (with
wo  different  RV/LV  ratio  thresholds,  1.5  and  1.0)  includ-
ng  191  normotensive  patients  with  PE,  a  58%  (95%  CI,
1--65%)  overall  negative  and  a  57%  positive  (95%  CI,  49--64%)
alue  of  RV  dilatation  were  reported  on  MDCT  for  pre-
icting  early  death,  yielding  a  relative  risk  for  in-hospital
ortality  of  2.28  (95%  CI,  0.9--5.9).13 Our  study  extends
hese  ﬁndings  to  a  population  of  severely  ill  patients  (all
ith  RV/LV  ratio  >1.0)  and  demonstrates  that  patients  with
V/LV  ratio  >1.8  have  an  11-fold  higher  risk  of  mortality
uring  medium-term  follow-up.  These  results  are  compa-
able  to  those  reported  by  Ghuysen  et  al.,14 in  which
atients  with  a  mean  RV/LV  ratio  of  1.52  had  a  mortality
f  25%.
To  date,  no  study  has  demonstrated  a  clear  beneﬁt
f  thrombolysis  over  an  anticoagulation-only  strategy  in
ntermediate-risk  patients,3 although  a  multicenter  trial  isR.  Baptista  et  al.
urrently  underway  to  assess  the  value  of  thrombolysis  in
hese  patients.21 The  majority  of  our  population  underwent
hrombolysis,  due  to  the  extensive  thrombus  burden  (72%
f  patients  with  >50%  arterial  obstruction  index),  severe  RV
ilatation  and  elevated  markers  of  myocardial  necrosis  in
ost  patients.  An  elevated  RV/LV  ratio  may  identify  high-risk
atients  who  will  beneﬁt  most  from  thrombolysis.  However,
he  low  positive  predictive  value  of  the  RV/LV  ratio  may
reclude  its  use  to  justify  treatment  escalation.
Our  study  is  limited  by  its  retrospective  design  and  the
mall  number  of  patients.  Moreover,  due  to  the  character-
stics  of  the  population,  selected  in  an  emergency  room
etting,  signiﬁcant  heterogeneity  among  patients,  particu-
arly  regarding  comorbidities,  cannot  be  excluded.  However,
his  reﬂects  the  actual  population  referred  to  our  hospi-
al  with  suspected  or  conﬁrmed  PE.  The  echocardiograms
ere  not  performed  by  the  same  operator  and  hence  we  do
ot  provide  quantitative  data  on  chamber  dimensions  or  RV
unction.  Although  the  MDCT  scans  were  immediately  inter-
reted  by  the  on-call  radiologist,  all  exams  were  thoroughly
eviewed  by  two  radiologists  who  were  blinded  to  outcomes
nd  to  echocardiography  results,  who  conﬁrmed  the  diag-
osis  of  PE  in  all  patients.  The  high  usage  of  thrombolytic
herapy  may  have  inﬂuenced  the  mortality  results.  None  of
he  MDCT  scans  were  ECG-gated.
In  conclusion,  in  this  selected  intermediate-  to  high-
isk  PE  population  with  markers  of  severe  right  ventricular
ysfunction,  most  of  whom  were  treated  with  thromboly-
is,  only  the  MDCT-derived  RV/LV  ratio  was  predictive  of
edium-term  death.  Regular  reporting  of  this  parameter
y  the  radiologist,  jointly  with  the  diagnosis  of  PE,  may
elp  the  attending  physician  to  risk-stratify  PE  patients.
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